Sarepta Therapeutics (SRPT) PT Lowered to $35 at Oppenheimer
Tweet
Share
E-mailGet Alerts SRPT Hot Sheet
Price: $22.99 --0%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 2
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 2
Join SI Premium – FREE
Oppenheimer analyst Andreas Argyrides lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $35.00 (from $37.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Freedom Broker Downgrades Ero Copper (ERO) to Hold
- Gerdau S.A. (GGBR4:BZ) (GGB) PT Raised to BRL34 at JPMorgan
- Oracle (ORCL) PT Raised to $210 at Morgan Stanley
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
